Gene · 1237
Papers2,300
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,300
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Prognostic value and immunological role of PTPN21 in pan-cancer analysis. | Cent Eur J Immunol | 2023 | 37692032 | PubTator, text mining | PubMed |
| Dynamic changes in macrophage subtypes during lung cancer progression and metastasis at single-cell resolution. | J Thorac Dis | 2023 | 37691661 | PubTator, text mining | PubMed |
| Potential Predictive Biomarkers of Systemic Drug Therapy for Hepatocellular Carcinoma: Anticipated Usefulness in Clinical Practice. | Cancers (Basel) | 2023 | 37686621 | PubTator, text mining | PubMed |
Cyclin dependent kinase inhibitor 3 (CDKN3) upregulation is associated with unfavorable prognosis in clear cell renal cell carcinoma and shapes tumor immune microenvironment: A bioinformatics analysis. | Medicine (Baltimore) | 2023 | 37682177 | PubTator, text mining | PubMed |
| Integration of single-cell RNA sequencing and bulk RNA transcriptome sequencing reveals a heterogeneous immune landscape and pivotal cell subpopulations associated with colorectal cancer prognosis. | Front Immunol | 2023 | 37675100 | PubTator, text mining | PubMed |
| Comprehensive analysis of ACKR family members in breast cancer using prognostic values. | Oncol Lett | 2023 | 37664667 | PubTator, text mining | PubMed |
| Drug conjugates for targeting regulatory T cells in the tumor microenvironment: guided missiles for cancer treatment. | Exp Mol Med | 2023 | 37653036 | PubTator, text mining | PubMed |
| Distribution and chemotactic mechanism of CD4+ T cells in traumatic tracheal stenosis. | Immun Inflamm Dis | 2023 | 37647429 | PubTator, text mining | PubMed |
| Fully closed cell sorter for immune cell therapy manufacturing. | Mol Ther Methods Clin Dev | 2023 | 37637381 | PubTator, text mining | PubMed |
| Eph receptor B6 shapes a cold immune microenvironment, inhibiting anti-cancer immunity and immunotherapy response in bladder cancer. | Front Oncol | 2023 | 37637034 | PubTator, text mining | PubMed |
| Post-translational modifications and immune responses in liver cancer. | Front Immunol | 2023 | 37609076 | PubTator, text mining | PubMed |
| Mechanisms of radiotherapy resistance and radiosensitization strategies for esophageal squamous cell carcinoma. | Mol Cancer | 2023 | 37598158 | PubTator, text mining | PubMed |
| CCL20 is a potential therapeutic target associated with immune infiltration in breast cancer. | J Int Med Res | 2023 | 37571985 | PubTator, text mining | PubMed |
| Targeting Members of the Chemokine Family as a Novel Approach to Treating Neuropathic Pain. | Molecules | 2023 | 37570736 | PubTator, text mining | PubMed |
| How do parasitic worms prevent diabetes? An exploration of their influence on macrophage and β-cell crosstalk. | Front Endocrinol (Lausanne) | 2023 | 37564976 | PubTator, text mining | PubMed |
| Protein regulator of cytokinesis 1: a potential oncogenic driver. | Mol Cancer | 2023 | 37563591 | PubTator, text mining | PubMed |
| Immune gene signatures as prognostic criteria for cancer patients. | Ther Adv Med Oncol | 2023 | 37547445 | PubTator, text mining | PubMed |
| Synthesis and structure-activity relationship study of phenoxybenzylpiperazine analogues as CCR8 agonists. | Bioorg Chem | 2023 | 37544272 | PubTator, text mining | PubMed |
| Single-cell transcriptome analysis reveals T population heterogeneity and functions in tumor microenvironment of colorectal cancer metastases. | Heliyon | 2023 | 37539320 | PubTator, text mining | PubMed |
| Thirty-five years since the discovery of chemotactic cytokines, interleukin-8 and MCAF: A historical overview. | Proc Jpn Acad Ser B Phys Biol Sci | 2023 | 37518010 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1237/papers?page=12